Discover the sigma metric as a tool for assessing assay performance and quality.
Diagnostic Equivalence Between POC and Laboratory-Based Systems
Malmö Study reveals: True Breast Tomosynthesis from Siemens increases breast cancer detection rate by 43%.
With the help of syngo.via and its Multi-foci Segmentation tool, Elba Etchebehere, MD, PhD, is able to accurately assess tumor burden by identifying individual lesions, which increases the prognostic power for her patients in Campinas, Brazil.
Markus Tiemann, MD, discussed molecular pathology, clinical decision-making in oncology, and his recent collaboration with the Siemens’ daughter NEO New Oncology in the field of molecular tumor diagnostics.